2013 Prostate Cancer Research Highlights
- PSMA Targeted Nano-Radioimmunotherapy using Curcumin for Advanced Prostate Cancer
- The Prognostic Potential of microRNA in Prostate Cancer
- Enhancing Radiation Therapy with Ultrasound-Stimulated Microbubbles
- Starving cancer: a therapy approach targeting cancer metabolic pathways
- Specific Antibody Targeting of Metastases in Prostate Cancer
- Novel Synthetic DNA Designer Molecules as Effective Therapeutic Agents against Prostate Cancer
- Targeting of the TMPRSS2/ERG Fusion Gene in Prostate Cancer Using Nanotechnology
- IGF1R Targeting for Better Prostate Cancer Imaging and Therapy
- A Novel Microscopy Technique for Better Prostate Cancer Detection and Prognosis
- Personalized Risk Assessment for Adverse Effects after Radiation Treatment for Prostate Cancer
- On the Path to Understanding, Identifying, and Eliminating Advanced Prostate Cancer: A Global Approach to Finding Key Mutations
- Personalized Immunotherapy: Attacking Prostate Cancer with Improved T Cell Engineering
- Clinical Testing of the Radiolabeled Anti-PSMA Antibody J591 in Patients with Non-Metastatic Castrate Resistant Prostate Cancer
- Improving Therapy for Advanced Prostate Cancer Using Nanoparticle-driven Drug Delivery
- The Prostate Cancer Biorepository Network (PCBN): A Valuable Resource for Prostate Cancer Researchers
- Detection of Prostate Cancer with a Non-Invasive Blood Assay